INTEGRATED BIOPHARMA INC
corporate_fare Company Profile
INTEGRATED BIOPHARMA INC (OTC:INBP) is a publicly traded company in the Consumer Defensive sector. Wiseek monitors INBP SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- INTEGRATED BIOPHARMA Reports Significant Quarterly and Nine-Month Losses Amidst Steep Revenue Decline
- Long-Term 5%+ Shareholder Group Exits Position Due to Estate Transfer
- Damon DeSantis Group Consolidates 41.3% Controlling Stake in Integrated BioPharma
- Subsidiary Amends Lease with Related Party, Increasing Annual Rent by 30% for Less Space
- Integrated BioPharma Reports Steep Q2 Loss and Revenue Decline, Bolstered by Strong Operating Cash Flow
Financial Snapshot
Fiscal year ended June 30, 2025
Revenue
$54.35M
Net Income
$808K
Diluted EPS
$0.03
Op. Cash Flow
$2.06M
Free Cash Flow
$1.87M
Gross Profit
$5.56M
Operating Income
$2.02M
Cash & Equivalents
$3.62M
Debt / Equity
0.00×
Net Margin
1.5%
Shares Outstanding
31.06M sh
Source: 10-K · filed 2025-09-23 · accession 0001437749-25-029711
show_chartPrice Chart
Loading chart...
feed INBP - Latest Insights
INBP
May 08, 2026, 4:07 PM EDT
Price at Filing:
$0.250
Real-time Price:
$0.18075
Change:
-$0.06925 (-28%)
Market Cap:
$5.614M
INBP
Apr 17, 2026, 4:17 PM EDT
Price at Filing:
$0.280622
Real-time Price:
$0.18075
Change:
-$0.099872 (-36%)
Market Cap:
$5.614M
INBP
Apr 17, 2026, 3:48 PM EDT
Price at Filing:
$0.280622
Real-time Price:
$0.18075
Change:
-$0.099872 (-36%)
Market Cap:
$5.614M
INBP
Feb 18, 2026, 4:23 PM EST
Price at Filing:
$0.2987
Real-time Price:
$0.18075
Change:
-$0.11795 (-39%)
Market Cap:
$5.614M
INBP
Feb 11, 2026, 4:24 PM EST
Price at Filing:
$0.300
Real-time Price:
$0.18075
Change:
-$0.11925 (-40%)
Market Cap:
$5.614M